Company intelligence / Profile preview
Noile-Immune Biotech Inc.
Minato, Tokyo, Japannoile-immune.com ↗
- Ownership
- Public · 4893
- Employees
- ~25
- Development stage
- Other
01
Overview
Noile‑Immune’s autologous CAR-T cell therapy for solid tumors has shown promising Phase 1 results with no dose-limiting toxicity observed and evidence of anti-tumor activity such as tumor shrinkage in patients with hepatocellular carcinoma. The company recently regained full rights to its lead programs from Takeda and continues clinical development independently.
- Therapeutic areas
- Oncology
- Modalities
- CAR-T cell therapies (chimeric antigen receptor T-cell)gene-modified immune cells
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
03
Partnerships
Takeda Pharmaceutical Company Limited (collaboration for next-gen CAR‑T; now returned assets)Adaptimmune Therapeutics plc (co-development using PRIME platform)Takara Bio Inc. (manufacturing partnership for NIB103 in Japan)
04
Financials
- Market cap
- $21.7M
- Total revenue
- $31.6K
- Enterprise value
- $-736.1K
Beyond the preview
Go deeper on Noile-Immune Biotech Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Noile-Immune Biotech Inc..